Medifoxamine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medifoxamine is an antidepressant drug which inhibits the reuptake of dopamine[1] and acts as an agonist at the 5HT2A and 5HT2C receptors.[2] It is used mainly in France.[3]
References
- ↑ Saleh S, Turner P. Ocular hypotensive effects of medifoxamine. British Journal of Clinical Pharmacology. 1992 Sep;34(3):269-71. PMID 1389953
- ↑ Martin P, Lemonnier F. The role of type 2 serotonin receptors, 5-HT2A and 5-HT2C, in depressive disorders: effect of medifoxamine. (French) L’Encephale. 1994 Jul-Aug;20(4):427-35. PMID 7988407
- ↑ Mitchell PB. Novel French antidepressants not available in the United States. Psychopharmacology Bulletin. 1995;31(3):509-19. PMID 8668756
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH